K. Haapala

发表

Androgen Receptor Alterations in Prostate Cancer Relapsed during a Combined Androgen Blockade by Orchiectomy and Bicalutamide

P. Koivisto, H. Helin, E. Hyytinen, 2001, Laboratory Investigation.

A de novo deletion of chromosome 15(q15.2q21.2) in a dysmorphic, mentally retarded child with congenital scalp defect.

P. Koivisto, K. Haapala, H. Koivisto, 1999, Clinical dysmorphology.

Androgen Receptor Mutations in High-Grade Prostate Cancer before Hormonal Therapy

P. Koivisto, O. Jänne, H. Helin, 2003, Laboratory Investigation.

Mapping DNA sequences in a human X-chromosome deletion which extends across the region of the Duchenne muscular dystrophy mutation.

H. Willard, K. Davies, A. de la Chapelle, 1985, American journal of human genetics.

Pattern of Somatic Androgen Receptor Gene Mutations in Patients with Hormone-Refractory Prostate Cancer

M. Vihinen, P. Koivisto, O. Jänne, 2002, Laboratory Investigation.

Androgen receptor amplification is associated with increased cell proliferation in prostate cancer.

P. Koivisto, H. Helin, T. Kuukasjärvi, 2007, Human Pathology.

Developing and validating a pancreatic cancer risk model for the general population using multi-institutional electronic health records from a federated network

Kai Jia, I. Kaplan, M. Palchuk, 2023, medRxiv.

Chromosomal changes in locally recurrent, hormone-refractory prostate carcinomas by karyotyping and comparative genomic hybridization.

T. Tammela, A. Rökman, P. Koivisto, 2001, Cancer genetics and cytogenetics.

Apolipoprotein E genotype is not linked to locally recurrent hormone-refractory prostate cancer

T. Lehtimäki, P. Koivisto, E. Ilveskoski, 2000, Prostate Cancer and Prostatic Diseases.

Trisomy 10p produced by recombination involving complex paternal translocation between chromosomes 1 and 10

K. Haapala, Sirpa Korhonen, Riitta Herva, 1983, Clinical genetics.